Nicotinic Receptors and Schizophrenia

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The study determines if a new preparation of a drug designed to treat schizophrenia is more slowly released into the body.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: VA Office of Research and Development

Criteria

Inclusion Criteria:

• Healthy volunteers: males and females who are incapable of pregnancy

Exclusion Criteria:

• Medical illnesses requiring acute treatment

• History of seizures

• Substance abuse including nicotine